Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)

NCT06005259 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

264

Enrollment

OTHER

Sponsor class

Conditions

Cardiotoxicity
Neoplasms
Chemotherapy Effect
Heart Failure

Interventions

DRUG: Spironolactone
DRUG: Placebo

Sponsor

University of Sao Paulo